UNITED STATES (VOP TODAY NEWS) — A new antibiotic, discovered in the ant gut by Russian scientists, could be equipped to fight against certain cancers.
Some Russian scientists have discovered in the intestines of ant species called Camponotus vagus, a strain of bacteria that produce a rare natural antibiotic, named nybomycine that more appeared with anti-cancer properties.
In recent years, scientists have discovered more and more super bacteria that are resistant to known antibiotics, biologists leave in search of new microorganisms and bacteria that could fight against contemporary threats.
This is why Russian scientists have been interested in ants that survive in poor sanitary conditions. They aimed to understand how these insects fought against all the microbes that surrounded them.
Thus, the ants are protected by streptomyces bacteria, which develop an “unknown antibiotic” capable of killing staphylococcus bacteria, which has proven that it can withstand commonly used drugs. In analyzing the structure of this new substance, the scientists concluded that it was nybomycin, an antibiotic little studied but already discovered in 1955.
What’s more, the researchers revealed that nybomycin also has the ability to fight cancer . In particular, he managed to stop the development of tumor cells in the lungs. This discovery has puzzled scientists for whom, for now, the operation of the new antibiotic is still unclear. Its practical application thus remains to be studied.
This article is written and prepared by our foreign editors writing for VOP from different countries around the world – edited and published by VOP staff in our newsroom.
Support The VOP from as little as $1 – it only takes a minute. Thank you.
We are the Voice of People — the only funding and support we get from people – we are categorically not funded by any political party, any government somewhere or from any grouping that supports certain interests – the only support that makes VOP possible came from you.
VOP Today News — Breaking news source, real-time coverage of the world’s events, life, politics, business, finance, economy, markets, war and conflict zones.
Contact us: [email protected]